There were no differences between IPF patients experiencing AE during follow-up (n = 19) and IPF patients who did not (n = 28) (p = 1.000) at the stable phase of the disease (Fig. 3B) in NHLRC2 expression. The gene discussed is NHLRC2; the disease is idiopathic pulmonary fibrosis.